{
    "nctId": "NCT05498311",
    "briefTitle": "Breast Cancer With Intraoperative Radiotherapy Followed by Hypofractionated External Beam Radiotherapy",
    "officialTitle": "Cosmetic Outcomes Following Conservative Surgery (With or Without Oncoplastic Surgery) for Breast Cancer With Intraoperative Radiotherapy (INTRABEAM) Followed by Hypofractionated External Beam Radiotherapy: a Phase II Trial",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 89,
    "primaryOutcomeMeasure": "Changes in Cosmetic results - BCCT",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically-confirmed diagnosis of invasive breast carcinoma and eligibility for conservative surgery (with or without oncoplastic surgery) and radiotherapy.\n* Not pregnant at diagnosis.\n* Signed informed consent form.\n* Age \u226545 years old.\n* Patients candidates to Intrabeam.\n* Patients with \u226560 years with the presence of one or more of the following adverse criteria after surgery:\n* Tumor size \\> 2.5 cm.\n* Extensive intraductal carcinoma (\u226525%)\n* Lymphovascular invasion.\n* Involved focal margins (\\<2mm) without ampliation surgery.\n\nExclusion Criteria:\n\n* Presence of distant metastasis.\n* Primary chemotherapy.\n* Lymph node involvement.\n* Negative hormonal receptors.\n* Diagnosis of any other infiltrating tumour except for adequately resected squamous or basal cell epitheliomas\n* Patients with collagen vascular disease (systemic lupus erythematosus, scleroderma, dermatomyositis).\n* Uncontrolled infection.\n* Concurrent treatment with other experimental treatments\n* Lack of signed informed consent form.",
    "sex": "FEMALE",
    "minimumAge": "45 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}